What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Searched for "active".
messages in brief
|
25/09/2017
Vienna (OTS) - The Ministry of Health and AGES Medizinmarktaufsicht/Federal Office for Safety in Health Care Austria, together with the Ministry of the Interior and the Ministry of Finance, were again able to seize numerous illegal medicines this…
21/09/2017
Two related clusters involving autochthonous transmission of chikungunya virus have been detected in the cities of Anzio and Rome, two areas located 60 km apart in the Lazio region of Italy. Transmission of this type, in areas where Aedes albopictusmosquitoes are established and at a time when environmental conditions are suitable for increased mosquito abundance and activity, is not unexpected.
Referenced at:
messages in brief
|
19/09/2017
EMA launches survey for patients and healthcare professionals on knowledge of reporting adverse reactions - Federal Office for Safety in Health Care (BASG) recommends participation The European Medicines Agency (EMA) has launched a -> Survey survey…
Safety warnings
|
Blood & Tissue
|
14/09/2017
Two related clusters involving autochthonous transmission of chikungunya virus have been detected in the cities of Anzio and Rome, two areas located 60 km apart in the Lazio region of Italy. Transmission of this type, in areas where Aedes albopictus mosquitoes are established and at a time when environmental conditions are suitable for increased mosquito abundance and activity, is not unexpected
Safety warnings
|
Blood & Tissue
|
11/09/2017
The Federal Office for Safety in Health Care was informed about the second confirmed human WNV infection (asymptomatic course, no known travel activity) in the area of Lower Austria.
Safety warnings
|
Blood & Tissue
|
04/09/2017
The Federal Office for Safety in Health Care was informed about several suspected cases of WNV in the area of Vienna, Lower Austria and Burgenland. Currently, a confirmed human WNV infection can be confirmed (no travel activity, only stays in Lower Austria and Burgenland).
29/08/2017
in accordance with the provisions of this Regulation, if: (a) the medicinal product contains a new active substance which, on the date of entry into force of this Regulation, was not authorised in the Community; [...] processes: · recombinant DNA technology, · controlled expression of genes coding for biologically active proteins in prokaryotes and eukaryotes including transformed mammalian cells, · hybridoma and monoclonal [...] antibody methods. 2. (Veterinary products). 3. Medicinal products for human use containing a new active substance which, on the date of entry into force of this Regulation, was not authorised in the Community
Referenced at:
Safety warnings
|
messages in brief
|
11/08/2017
The medicinal product "Melphalan Koanaa 50 mg i.v. powder and solvent for the preparation of a solution for injection or infusion" (active substance Melphalan) does not have a valid marketing authorization in Austria, but was placed on the market by…
Safety warnings
|
Medicines
|
11/08/2017
The drug "Melphalan Koanaa 50 mg i.v. Powder and Solvent for Solution for Injection or Solution for Infusion" is being recalled due to suspected drug counterfeiting.
Recall
|
Medicines
|
27/07/2017
The marketing authorization holder has informed its supplied customers in a letter dated July 25, 2017, that a test result within the scope of a stability study showed a reduced active ingredient content. Therefore, the batch 559CG placed on the…